Cardinal Health, distributor of healthcare products to hospitals, clinics and others, Wednesday reported fiscal Q4 results ended June 30 which beat expectations and issued downside EPS guidance for FY18. The company posted fiscal Q4 adjusted EPS of $1.31, seven cents above the Street view as compiled by Capital IQ, and also above the $1.14 reported a year earlier.
Cardinal Health reported fiscal Q4 revenue of $32.97 billion, a little above the Street view of $32.73 billion, and above the $31.38 billion reported a year earlier. In initial fiscal 2018 guidance, the company said the “guidance range for non-GAAP EPS from continuing operations is $4.85 to $5.10,” and added it is targeting “at least $5.60” for fiscal 2019. Analysts are expecting FY18 EPS of $5.25 per share.